About Me

As a partner in our Finance & Financial Regulation Group in London, I have in-depth experience in cross-border and domestic debt finance, syndicate financings, capital markets, venture capital finance, structured finance and restructurings. I am based in our London office but work as part of our international finance team.

Working on behalf of European and US private equity sponsors, lenders, borrowers, hedge funds, venture capital firms, development banks and other corporates, I have extensive expertise in the tech, energy, fintech, manufacturing, insurance and sports & leisure sectors and a particular interest in private equity, venture capital and alternative finance.

My practice includes acquisition and leveraged finance – senior and mezzanine – and debt restructurings, real estate finance, debt capital markets, private placements and venture capital.

Before joining Bird & Bird, I was a partner at another international law firm. My international credentials include periods working in London and Tokyo, advising clients throughout Europe, the US, Asia and the Middle East. I speak English, French and Persian.
Education

Studied

  • Cambridge, LLM, Law (First Class)
  • The London School of Economics, LLB, Law (First Class)

Admissions

  • Law Society of England & Wales (2002)
Testimonials Carousel Megaphone

Testimonials

'Samrad is a real rising star' with a 'great work ethic and commerciality'. 'Samrad Nazer is an exceptional transactional lawyer whose breadth of knowledge across the banking and finance space means he always has a busy practice.' 'Samrad Nazer provides robust and no-nonsense advice.'

Legal 500

Samrad is highly regarded by both clients and peers, and he is often applauded for his 'clarity of approach' and his 'constructive and sensible contribution to a deal'.

Chambers & Partners

News & Deals

More News & Deals

News

Bird & Bird advises BPD Zenith on its acquisition of Peacock Engineering Limited

Aug 17 2023

Read More

Deal

Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB

May 31 2020

Read More

What's on TwoBirds TV?

More Videos